Peer-reviewedCC BY-NC-ND 4.0Scientific Reports
Advancing asparaginase-based therapy for acute lymphoblastic leukemia through computational immunoengineering and molecular dynamics simulations
Related
- 1017 Computational design of de novo antigen-specific T cell receptors using AI optimization and long-time-scale molecular simulations for targeted cancer immunotherapy
- RBC Deformability During Acute Lymphoblastic Leukemia Treatment
- Gut microbiota dysbiosis in pediatric acute lymphoblastic leukemia: clinical consequences, mechanistic insights, and microbiota-targeted interventions.
- Targeting Artemis sensitizes acute lymphoblastic leukemia cells to topoisomerase 2 poisons by disrupting DNA-PKcs-dependent repair.
- Advancing Targeted Nanoparticle mRNA Delivery Using Machine Learning
BibTeX
@article{soleimanzadeh2026advancing,
title = {{Advancing asparaginase-based therapy for acute lymphoblastic leukemia through computational immunoengineering and molecular dynamics simulations}},
author = {Leila Sarafan Soleimanzadeh and Maryam Azimzadeh Irani and Bita Amiri Hazaveh and Ayla Esmaeilzadeh},
journal = {Scientific Reports},
year = {2026},
month = oct,
doi = {10.1038/s41598-026-74992-5},
url = {https://www.nature.com/articles/s41598-026-74992-5},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Advancing asparaginase-based therapy for acute lymphoblastic leukemia through computational immunoengineering and molecular dynamics simulations
AU - Leila Sarafan Soleimanzadeh
AU - Maryam Azimzadeh Irani
AU - Bita Amiri Hazaveh
AU - Ayla Esmaeilzadeh
PY - 2026
DA - 2026/10/06
JO - Scientific Reports
DO - 10.1038/s41598-026-74992-5
UR - https://www.nature.com/articles/s41598-026-74992-5
SN - 2045-2322
ER -